Atour Lifestyle Holdings $52 million IPO
We advised Atour on its IPO and Nasdaq listing
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
DFZQ $300 million bonds offering
The investment-grade bonds are due 2025
InnoCare Pharma RMB2.9 billion Shanghai IPO
This is the largest A-share listing by an overseas-listed biotechnology company in 2022 so far
Tencent Music Entertainment Group secondary listing
We advised Tencent Music Entertainment Group on its secondary listing by way of introduction on the HKEX
Interra Acquisition HK$1 billion IPO
We advised the SPAC on its IPO and HKEX listing
Biocytogen HK$549 million IPO
We advised Biocytogen on its IPO and HKEX listing
Red Star Macalline Group $249.7 million credit enhanced bonds offering
We advised the issuer on the credit enhanced bonds offering
Akeso HK$582 million share placement
We advised Akeso in the placement of new shares
Tuya global offering and dual primary listing on the Hong Kong Stock Exchange
We advised Tuya Inc. on its HK$141 million global offering and dual primary listing on the HKEX
Jiangsu Zhongnan Construction Group exchange offers
The exchange offers involve guaranteed senior notes due this year